Very high specific activity (A(S)) Re-186g could be produced by either proton or deuteron cyclotron irradiation on highly enriched W-186 target in no-carrier-added (NCA) form, leading to a A(S) very close to the theoretical carrier free (CF) value of 6.88 GBq mu g(-1). Thick Target Yields (TTYs), obtained irradiating both thick metal W targets of natural isotopic composition and highly enriched powdered W-186 targets, were measured at different particles energies taking into account high accuracy and precision. The evaluation of radionuclidic purities of Re-186g obtained activating highly enriched W-186 by both p and d were also carried out and accurately compared. The thin-target excitation functions for all Re (A = 181, 182, 183, 184, 186...
186gRe (T1/2 = 3.7183 d, E(β−)mean = 346.7 keV, I(β−)mean = 92.59%), a mixed beta and γ-emitter show...
The applications of the radionuclides play a fundamental role in life sciences; their greater user i...
Patients with primary breast, prostate and lung cancer have a high frequency of bone metastases, ran...
Very high specific activity(AS) 186gRe could be produced by either proton or deuteron cyclotron irra...
Very high specific activity (AS) 186gRe could be produced by either proton or deuteron cyclotron irr...
The 186gRe can be produced in carrier-added (CA) form by (n,y) reaction on enriched 185Re target in ...
Excitation functions and thin-target yields for the 181 12186gRe radionuclides have been measured by...
Excitation functions, thin- and thick-target yields (tty and TTY) for the 181-186Re radionuclides we...
Excitation functions, thin- and thick-target yields for the 181 12186gRe and 187Wradionuclideswereme...
Excitation functions, thin- and thick-target yields for the 181-186gRe and 187W radionuclides were m...
The 186gRe radionuclide is a ß-,¿ emitter that, thanks to its suitable nuclear properties (t1/2 = 90...
Excitation functions and thin-target yields for the 181-186gRe radionuclides were measured by the st...
186gRe is a ¿-¿¿¿emitter used in metabolic radiotherapy, thanks to its suitable nuclear properties (...
Excitation functions, thin- and thick-target yields (tty and TTY) for the 181-186Re radionuclides ha...
Excitation functions, thin- and thick-target yields for the 181-186Re radionuclides were measured by...
186gRe (T1/2 = 3.7183 d, E(β−)mean = 346.7 keV, I(β−)mean = 92.59%), a mixed beta and γ-emitter show...
The applications of the radionuclides play a fundamental role in life sciences; their greater user i...
Patients with primary breast, prostate and lung cancer have a high frequency of bone metastases, ran...
Very high specific activity(AS) 186gRe could be produced by either proton or deuteron cyclotron irra...
Very high specific activity (AS) 186gRe could be produced by either proton or deuteron cyclotron irr...
The 186gRe can be produced in carrier-added (CA) form by (n,y) reaction on enriched 185Re target in ...
Excitation functions and thin-target yields for the 181 12186gRe radionuclides have been measured by...
Excitation functions, thin- and thick-target yields (tty and TTY) for the 181-186Re radionuclides we...
Excitation functions, thin- and thick-target yields for the 181 12186gRe and 187Wradionuclideswereme...
Excitation functions, thin- and thick-target yields for the 181-186gRe and 187W radionuclides were m...
The 186gRe radionuclide is a ß-,¿ emitter that, thanks to its suitable nuclear properties (t1/2 = 90...
Excitation functions and thin-target yields for the 181-186gRe radionuclides were measured by the st...
186gRe is a ¿-¿¿¿emitter used in metabolic radiotherapy, thanks to its suitable nuclear properties (...
Excitation functions, thin- and thick-target yields (tty and TTY) for the 181-186Re radionuclides ha...
Excitation functions, thin- and thick-target yields for the 181-186Re radionuclides were measured by...
186gRe (T1/2 = 3.7183 d, E(β−)mean = 346.7 keV, I(β−)mean = 92.59%), a mixed beta and γ-emitter show...
The applications of the radionuclides play a fundamental role in life sciences; their greater user i...
Patients with primary breast, prostate and lung cancer have a high frequency of bone metastases, ran...